NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE85353 Query DataSets for GSE85353
Status Public on Jun 18, 2020
Title DNA methylation repels binding of hypoxia-inducible transcription factors to maintain tumour immunotolerance [RNA]
Organisms Homo sapiens; Mus musculus
Experiment type Expression profiling by high throughput sequencing
Summary Background: Hypoxia is pervasive in cancer and other diseases. Cells sense and adapt to hypoxia by activating hypoxia-inducible transcription factors (HIFs), but it is still an outstanding question why cell types differ in their transcriptional response to hypoxia.

Results: Here, we report that HIFs fail to bind CpG dinucleotides that are methylated in their consensus binding sequence, both in in vitro biochemical binding assays and in vivo studies of differentially methylated isogenic cell lines. Based on in silico structural modelling, we show that 5-methylcytosine indeed causes steric hindrance in the HIF binding pocket. A model wherein cell-type-specific methylation landscapes, as laid-down by the differential expression and binding of other transcription factors under normoxia control cell-type-specific hypoxia responses is observed. We also discover ectopic HIF binding sites in repeat regions which are normally methylated. Genetic and pharmacological DNA demethylation, but also cancer-associated DNA hypomethylation, expose these binding sites, inducing HIF-dependent expression of cryptic transcripts. In line with such cryptic transcripts being more prone to cause double-stranded RNA and viral mimicry, we observe low DNA methylation and high cryptic transcript expression in tumours with high immune checkpoint expression, but not in tumours with low immune checkpoint expression, where they would compromise tumour immunotolerance. In a low-immunogenic tumour model, DNA demethylation upregulates cryptic transcript expression in a HIF-dependent manner, causing immune activation and reducing tumour growth.

Conclusions: Our data elucidate the mechanism underlying cell-type specific responses to hypoxia, and suggest DNA methylation and hypoxia to underlie tumour immunotolerance.
 
Overall design Examination of differentially expressed genes upon exposure to 0.5% O2 in 3 human cancer cell lines, one demethylated cancer cell line and mouse Hif1b-WT and Hif1b-KO cell lines by RNA-seq
 
Contributor(s) D’Anna F, Van Dyck L, Xiong J, Zhao H, Berrens RV, Qian J, Bieniasz-Krzywiec P, Chandra V, Schoonjans L, Matthews J, De Smedt J, Minnoye L, Amorim R, Khorasanizadeh S, Yu Q, Zhao L, De Borre M, Savvides SN, Simon C, Carmeliet P, Reik W, Rastinejad F, Mazzone M, Thienpont B, Lambrechts D
Citation(s) 32718321
Submission date Aug 09, 2016
Last update date Aug 03, 2020
Contact name Jieyi Xiong
Organization name VIB-KULeuven Center for Cancer Biology
Street address Herestraat 49, box 912
City Leuven
ZIP/Postal code 3000
Country Belgium
 
Platforms (5)
GPL13112 Illumina HiSeq 2000 (Mus musculus)
GPL16791 Illumina HiSeq 2500 (Homo sapiens)
GPL17021 Illumina HiSeq 2500 (Mus musculus)
Samples (214)
GSM3385837 4T1_tumour_RNAseq_PBS_r1
GSM3385838 4T1_tumour_RNAseq_PBS_r2
GSM3385839 4T1_tumour_RNAseq_PBS_r3
This SubSeries is part of SuperSeries:
GSE85356 DNA methylation repels binding of hypoxia-inducible transcription factors to maintain tumour immunotolerance
Relations
BioProject PRJNA338259
SRA SRP081130

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE85353_RAW.tar 33.6 Mb (http)(custom) TAR (of TSV, TXT)
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap